JianpingJiang  MD

Chief physician
National Clinical Research Center for kidney Disease
Guangdong Provincial Institute of Nephrology
Nanfang Hospital, Sountern Medical University

Dr. Jiang jianping graduated from the Second Military Medical University in 1989 with a Bachelor  Degree in Medicine. He got his Master Degree from First Military Medical University in Internal Medicine. He is mainly in charge of the peritoneal dialysis section of the nephrology department. He is also the member of the expert database on technical appraisal for the medical negligence of Guangzhou medical association. Now he is the chief physician and associate professor of nephrology in Nanfang Hospital of Southern Medical University.
 
He has been working in the forefront of clinical work with rich experience. His specialty lies in diagnosis and treatment of chronic kidney disease, the treatment of critically ill patients, the treatment of peritoneal dialysis, renal puncture biopsy, hemodialysis patient's liver biopsy and surgical peritoneal dialysis tube placement. His research interests included the prevention and treatment of chronic renal failure. He has presided over National Natural Science Foundation Program, Guangdong natural Science Foundation Program and so on.

He published more than 40 papers in renowned journals. Dr. Jiang has won the second prize of National Science and Technology Award, first prize of Guangdong Science and Technology Progress Award, first prize in the Chinese Medical Science and Technology Award, and the second prize in the Military Science and Technology Award.

Selected Research and Publication

1.Jianping Jiang, Pingyan Chen, Jianghua Chen, Xueqing Yu, Di Xie, Changlin Mei, Fei Xiong, Wei Shi, Wei Zhou, Xusheng Liu, Shiren Sun, Ping Zhang, Xiao Yang, Yixiang Zhang, Yanmin Zhang, Xinling Liang, Zhimin Zhang, Qizhan Lin, Yan Yu, Toshio Miyata, Jianwei Tian, Min Liang, Weihong Luo, Xin Xu, Fanfan Hou. Accumulation of tissue advanced glycation end products correlated with glucose exposure dose and associated with cardiovascular morbidity in patients on peritoneal dialysis. Atherosclerosis, 2012, 224:187-194. 

2.Fan Fan Hou, Jian Ping Jiang, Jun Qi Guo, et al. Receptor for advanced glycation end products on huaman synovial fibroblasts: Role in pathogenesis of dialysis-related amyloidosis. J Am Soc Nephrol, 2002, 13:1296-1306.  

3.Hou FF, Zhang X, Zhang GH, Xie D, Chen PY, Zhang WR, Jiang JP, Liang M, Wang GB, Liu ZR, Geng RW. Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med, 2006, 354:131-140.
 
4.Hou FF, Xie D, Zhang X, Zhang GH, Chen PY, Zhang WR, Liang M, Guo ZJ, Jiang JP. Renoprotection of optimal antiproteinuric doses(ROAD) study: A randomized controlled study of benazepril and losartan in chronic renal insufficiency. J Am Soc Nephrol, 2007,18:1889-1898. 

5.Fanfan Hou, Jianping Jiang, Jianghua Chen, Xueqing Yu, Qiugen Zhou, Pingyan Chen, Changlin Mei, Fei Xiong, Wei Shi, Wei Zhou, Xusheng Liu, Shiren Sun, Di Xie, Jun Liu, Ping Zhang, Xiao Yang, Yixiang Zhang, Yanmin Zhang, Xinling Liang, Zhimin Zhang, Qizhan Lin, Yan Yu, Shengjie Wu, Xin Xu. China collaborative study on dialysis (CCSD): cardiovascular diseases in patients on maintenance dialysis. BMC Nephrology, 2012,13:94